The Trump administration plans to pump millions of dollars into producing more medications in the U.S. as the coronavirus pandemic heightens longstanding concerns about the fragility of the global drug supply chain.
Freight-payment levels provide a good snapshot of current economic activity, and judging by the trend detected by U.S. Bank for the first quarter of this year, the news isn’t good.